Alnylam Pharmaceuticals
ALNY
#802
Rank
HK$252.48 B
Marketcap
HK$1,887
Share price
1.51%
Change (1 day)
-45.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company